Amodei guessed that powerful AI could at least 10x the rate of these biological discoveries, giving the next 50-100 years of biological progress in 5-10 years.

This is a conditional prediction about the period after 'powerful AI' arrives. It is judged 5–10 years after powerful AI (as Amodei defines it) is widely recognised to exist. TRUE: within 10 years of that point, the rate of major biological discoveries is at least 10 times the pre-AI baseline. This should show as roughly 50–100 years' worth of progress at the historical pace, judged by expert assessments and counts of landmark discoveries or approved therapies. MOSTLY TRUE: the acceleration is close to 10 times (for example 7–10 times), or 50+ years of progress arrives slightly beyond 10 years. MIXED: there is substantial acceleration of about 3–7 times. MOSTLY FALSE: acceleration is only modest (under about 3 times). FALSE: there is no meaningful acceleration of biological discovery attributable to AI. If powerful AI has not arrived, or 5 years have not passed since it did, the claim cannot be resolved.

Set before the research began.

1. E1 Are Amodei’s Medical Predictions on Track for 2028-2033? ETC Journal · 22 June 2026

   “The field is moving faster than it did before deep learning entered biology, but it is not yet moving fast enough to make those outcomes likely on that schedule.”

2. E2 Decade of AI in Drug Discovery: Hype or Reality? International Journal of Pharmaceutical Sciences and Drug Research (IJPSDR) · 30 May 2026

   “The data reveal a bifurcated picture: AI demonstrably outperforms historical industry norms in Phase I (80–90% vs. ~52% success), reflecting genuine superiority in molecular safety engineering and ADMET prediction, while Phase II success (~40%) remains statistically indistinguishable from conventional drug development (~37%).”

3. E3 Decade of AI in Drug Discovery: Hype or Reality? International Journal of Pharmaceutical Sciences and Drug Research (IJPSDR) · 30 May 2026

   “Yet as of early 2026, no AI-discovered drug has received regulatory approval.”

4. E4 Artificial intelligence tools expand scientists’ impact but contract science’s focus - Nature Nature · 14 January 2026

   “Scientists who engage in AI-augmented research publish 3.02 times more papers, receive 4.84 times more citations and become research project leaders 1.37 years earlier than those who do not.”

The criteria say the claim can only be judged 5–10 years after 'powerful AI' is widely recognised to exist. No evidence shows that has happened, so the 5-year window has not been shown to have passed. E1 (June 2026) puts Amodei's timeline at 2028–2033 and says biology is moving faster than before deep learning, but not yet fast enough. E3 says no AI-discovered drug had regulatory approval as of early 2026. The outcome is not settled yet, so the verdict is not_yet_due.